Phathom Pharmaceuticals Inc (PHAT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: PHAT Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-04-08	2025-04-07	S Sale	Henderson Molly CFO and CBO Officer	1,000 -3.9% 4.55 USD 16,740	1,000 -3.9%	4.55	USD 100,000
2025-03-17	2025-03-13	B Purchase	Parikh Asit Non-Executive Director	10,000 +13.2% 4.42 USD 44,200	10,000 +13.2%	4.42	USD 44,200
2025-01-23	2025-01-21	PS Planned sale	Nabulsi Azmi Chief Operating Officer Officer	7,886 -3.3% 6.59 USD 51,957	7,886 -3.3%	6.59	USD 51,957
2025-01-23	2025-01-21	PS Planned sale	Henderson Molly CFO and CBO Officer	6,583 -6.6% 6.59 USD 43,371	6,583 -6.6%	6.59	USD 43,371
2025-01-23	2025-01-21	PS Planned sale	Curran Terrie President and Chief Executive Executive Director	19,109 -5.0% 6.59 USD 125,884	19,109 -5.0%	6.59	USD 125,884
2024-12-20	2024-12-19	S Sale	Nabulsi Azmi Chief Operating Officer Officer	1,118 -0.5% 8.00 USD 8,944	1,118 -0.5%	8.00	USD 8,944
2024-12-20	2024-12-19	S Sale	Henderson Molly CFO and CBO Officer	1,291 -1.3% 8.00 USD 10,328	1,291 -1.3%	8.00	USD 10,328
2024-12-16	2024-12-13	B Purchase	Parikh Asit Non-Executive Director	10,000 +15.3% 8.12 USD 81,248	10,000 +15.3%	8.12	USD 81,248
2024-12-16	2024-12-13	B Purchase	KARBE FRANK Non-Executive Director	12,500 +28.1% 7.93 USD 99,084	12,500 +28.1%	7.93	USD 99,084
2024-07-17	2024-07-15	PS Planned sale	Henderson Molly CFO and CBO Officer	4,325 -4.2% 11.72 USD 50,689	4,325 -4.2%	11.72	USD 50,689
2024-07-17	2024-07-15	PS Planned sale	Curran Terrie President and Chief Executive Executive Director	33,848 -8.2% 11.72 USD 396,699	33,848 -8.2%	11.72	USD 396,699
2024-07-17	2024-07-15	PS Planned sale	Nabulsi Azmi Chief Operating Officer Officer	10,901 -4.3% 11.72 USD 127,760	10,901 -4.3%	11.72	USD 127,760
2024-04-10	2024-04-08	S Sale	Henderson Molly CFO and CBO Officer	3,435 -3.5% 11.10 USD 38,129	3,435 -3.5%	11.10	USD 38,129
2024-03-26	2024-03-22	PS Planned sale	Curran Terrie President and Chief Executive Executive Director	16,851 -3.9% 9.11 USD 153,513	16,851 -3.9%	9.11	USD 153,513
2024-01-25	2024-01-24	S Sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	3,703,703 -49.7% 8.10 USD 29,999,994	3,703,703 -49.7%	8.10	USD 29,999,994
2024-01-22	2024-01-19	PS Planned sale	Henderson Molly CFO and CBO Officer	6,307 -6.0% 7.75 USD 48,900	6,307 -6.0%	7.75	USD 48,900
2023-11-21	2023-11-20	S Sale	Henderson Molly CFO and CBO Officer	2,127 -2.0% 7.24 USD 15,403	2,127 -2.0%	7.24	USD 15,403
2023-11-08	2023-11-08	B Purchase	Parikh Asit Non-Executive Director	2,500 +4.8% 7.80 USD 19,500	2,500 +4.8%	7.80	USD 19,500
2023-11-08	2023-11-07	B Purchase	Parikh Asit Non-Executive Director	4,000 +8.2% 7.76 USD 31,040	4,000 +8.2%	7.76	USD 31,040
2023-11-08	2023-11-06	B Purchase	Parikh Asit Non-Executive Director	1,000 +2.1% 8.04 USD 8,040	1,000 +2.1%	8.04	USD 8,040
2023-11-03	2023-11-01	S Sale	Henderson Molly CFO and CBO Officer	11,681 -10.0% 8.95 USD 104,545	11,681 -10.0%	8.95	USD 104,545
2023-11-03	2023-11-01	S Sale	Henderson Molly CFO and CBO Officer	811 -0.7% 7.80 USD 6,326	811 -0.7%	7.80	USD 6,326
2023-06-05	2023-06-02	PS Planned sale	Henderson Molly CFO and CBO Officer	1,960 -2.8% 11.41 USD 22,368	1,960 -2.8%	11.41	USD 22,368
2023-05-23	2023-05-22	PS Planned sale	Henderson Molly CFO and CBO Officer	2,110 -2.9% 12.87 USD 27,165	2,110 -2.9%	12.87	USD 27,165
2023-04-11	2023-04-11	B Purchase	Nabulsi Azmi Chief Operating Officer Officer	10,000 +11.2% 8.26 USD 82,600	10,000 +11.2%	8.26	USD 82,600
2023-04-11	2023-04-10	B Purchase	Parikh Asit Non-Executive Director	1,000 +4.4% 7.55 USD 7,550	1,000 +4.4%	7.55	USD 7,550
2023-04-07	2023-04-06	PS Planned sale	Henderson Molly CFO and CBO Officer	3,439 -4.5% 7.27 USD 25,002	3,439 -4.5%	7.27	USD 25,002
2023-04-07	2023-04-06	B Purchase	Curran Terrie President and Chief Executive Executive Director	12,919 +7.4% 7.82 USD 101,025	12,919 +7.4%	7.82	USD 101,025
2023-03-03	2023-03-01	PS Planned sale	Henderson Molly CFO and CBO Officer	2,032 -2.6% 8.53 USD 17,335	2,032 -2.6%	8.53	USD 17,335
2023-03-03	2023-03-01	PS Planned sale	Curran Terrie President and Chief Executive Executive Director	1,436 -0.8% 8.54 USD 12,265	1,436 -0.8%	8.54	USD 12,265
2023-02-14	2023-02-13	B Purchase	Parikh Asit Non-Executive Director	5,000 +28.6% 7.73 USD 38,660	5,000 +28.6%	7.73	USD 38,660
2023-01-20	2023-01-20	S Sale	Curran Terrie President and Chief Executive Executive Director	5,821 -3.2% 8.20 USD 47,729	5,821 -3.2%	8.20	USD 47,729
2023-01-12	2023-01-12	B Purchase	Parikh Asit Non-Executive Director	5,000 +40.0% 7.00 USD 35,000	5,000 +40.0%	7.00	USD 35,000
2022-11-23	2022-11-21	S Sale	Henderson Molly CFO and CBO Officer	2,159 -4.7% 9.60 USD 20,726	2,159 -4.7%	9.60	USD 20,726
2022-11-23	2022-11-21	S Sale	Curran Terrie President and Chief Executive Executive Director	1,526 -1.8% 9.60 USD 14,650	1,526 -1.8%	9.60	USD 14,650
2022-05-16	2022-05-16	B Purchase	Nabulsi Azmi Chief Operating Officer Officer	20,000 +2.6% 8.16 USD 163,288	20,000 +2.6%	8.16	USD 163,288
2022-05-16	2022-05-13	B Purchase	Henderson Molly CFO and CBO Officer	6,000 0.00 USD 0	6,000	0.00	USD 0
2022-05-16	2022-05-13	B Purchase	Curran Terrie President and Chief Executive Executive Director	20,500 +46.5% 7.41 USD 151,835	20,500 +46.5%	7.41	USD 151,835
2022-05-16	2022-05-12	B Purchase	Parikh Asit Non-Executive Director	12,500 +inf% 8.00 USD 100,000	12,500 +inf%	8.00	USD 100,000
2022-03-16	2022-03-14	S Sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	18 -0.0% 19.00 USD 342	18 -0.0%	19.00	USD 342
2021-11-08	2021-11-04	S Sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	1,000,000 -90.9% 20.85 USD 20,850,000	1,000,000 -90.9%	20.85	USD 20,850,000
2021-11-08	2021-11-04	S Sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	1 -0.0% 19.00 USD 19	1 -0.0%	19.00	USD 19
2021-10-08	2021-10-08	S Sale	Socks David A Non-Executive Director	2,529 -0.2% 32.05 USD 81,052	2,529 -0.2%	32.05	USD 81,052
2021-10-08	2021-10-07	PS Planned sale	Socks David A Non-Executive Director	15,471 -1.3% 32.66 USD 505,343	15,471 -1.3%	32.66	USD 505,343
2021-06-29	2021-06-29	S Sale	Socks David A Non-Executive Director	13,960 -1.1% 34.00 USD 474,657	13,960 -1.1%	34.00	USD 474,657
2021-06-29	2021-06-28	S Sale	Socks David A Non-Executive Director	156 -0.0% 35.09 USD 5,474	156 -0.0%	35.09	USD 5,474
2021-06-29	2021-06-28	PS Planned sale	Socks David A Non-Executive Director	25,884 -2.0% 34.07 USD 881,811	25,884 -2.0%	34.07	USD 881,811
2021-06-29	2021-06-28	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	370 -0.0% 35.08 USD 12,980	370 -0.0%	35.08	USD 12,980
2021-06-29	2021-06-25	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	1,250 -0.1% 36.07 USD 45,088	1,250 -0.1%	36.07	USD 45,088
2021-06-29	2021-06-25	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	22,881 -2.5% 35.46 USD 811,360	22,881 -2.5%	35.46	USD 811,360
2021-06-25	2021-06-24	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	10,848 -1.2% 35.14 USD 381,199	10,848 -1.2%	35.14	USD 381,199
2021-06-25	2021-06-23	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	200 -0.0% 35.00 USD 7,000	200 -0.0%	35.00	USD 7,000
2021-06-23	2021-06-22	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	100 -0.0% 35.00 USD 3,500	100 -0.0%	35.00	USD 3,500
2021-06-23	2021-06-21	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	9,294 -1.0% 35.31 USD 328,171	9,294 -1.0%	35.31	USD 328,171
2021-06-21	2021-06-18	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	5,398 -0.6% 35.13 USD 189,632	5,398 -0.6%	35.13	USD 189,632
2021-06-21	2021-06-17	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	3,305 -0.4% 35.08 USD 115,939	3,305 -0.4%	35.08	USD 115,939
2021-06-16	2021-06-14	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	2,826 -0.3% 35.06 USD 99,080	2,826 -0.3%	35.06	USD 99,080
2021-06-11	2021-06-10	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	2,102 -0.2% 35.14 USD 73,864	2,102 -0.2%	35.14	USD 73,864
2021-06-11	2021-06-09	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	1,191 -0.1% 35.28 USD 42,018	1,191 -0.1%	35.28	USD 42,018
2021-06-09	2021-06-08	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	100 -0.0% 35.00 USD 3,500	100 -0.0%	35.00	USD 3,500
2021-06-09	2021-06-07	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	2,264 -0.2% 35.05 USD 79,353	2,264 -0.2%	35.05	USD 79,353
2021-06-04	2021-06-02	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	4,300 -0.5% 35.18 USD 151,274	4,300 -0.5%	35.18	USD 151,274
2021-06-02	2021-06-01	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	3,967 -0.4% 36.20 USD 143,605	3,967 -0.4%	36.20	USD 143,605
2021-06-02	2021-06-01	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	7,244 -0.8% 35.55 USD 257,524	7,244 -0.8%	35.55	USD 257,524
2021-06-02	2021-05-28	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	2,104 -0.2% 37.55 USD 79,005	2,104 -0.2%	37.55	USD 79,005
2021-06-02	2021-05-28	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	2,668 -0.3% 36.40 USD 97,115	2,668 -0.3%	36.40	USD 97,115
2021-06-02	2021-05-28	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	4,133 -0.4% 35.37 USD 146,184	4,133 -0.4%	35.37	USD 146,184
2021-05-26	2021-05-25	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	548 -0.1% 36.59 USD 20,051	548 -0.1%	36.59	USD 20,051
2021-05-26	2021-05-25	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	10,399 -1.0% 36.16 USD 376,028	10,399 -1.0%	36.16	USD 376,028
2021-05-26	2021-05-24	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	1,683 -0.2% 36.10 USD 60,756	1,683 -0.2%	36.10	USD 60,756
2021-05-26	2021-05-24	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	8,911 -0.9% 35.58 USD 317,053	8,911 -0.9%	35.58	USD 317,053
2021-05-24	2021-05-21	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	11,648 -1.1% 35.74 USD 416,300	11,648 -1.1%	35.74	USD 416,300
2021-05-24	2021-05-20	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	7,098 -0.7% 35.10 USD 249,140	7,098 -0.7%	35.10	USD 249,140
2021-05-18	2021-05-14	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	100 -0.0% 35.00 USD 3,500	100 -0.0%	35.00	USD 3,500
2021-05-14	2021-05-13	PS Planned sale	TAKEDA PHARMACEUTICAL CO LTD Large shareholder	100 -0.0% 35.33 USD 3,533	100 -0.0%	35.33	USD 3,533

Phathom Pharmaceuticals Inc (PHAT)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by